Matches in Nanopublications for { ?s ?p "[The expression of CK5, EGFR, P-cadherin, CK14, Vimentin and p63 were evaluated in 462 invasive breast carcinomas to determine their sensitivity and specificity for BLBC identification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP346807.RAv4IClXV66H7VVv6d-GxhLMul36BdqRXfQnA-ORA7NqQ130_assertion description "[The expression of CK5, EGFR, P-cadherin, CK14, Vimentin and p63 were evaluated in 462 invasive breast carcinomas to determine their sensitivity and specificity for BLBC identification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP346807.RAv4IClXV66H7VVv6d-GxhLMul36BdqRXfQnA-ORA7NqQ130_provenance.
- NP322033.RABTiuQaN6oCbIcyEUQggn1n0ZhIzG0Qr14xefF1llhes130_assertion description "[The expression of CK5, EGFR, P-cadherin, CK14, Vimentin and p63 were evaluated in 462 invasive breast carcinomas to determine their sensitivity and specificity for BLBC identification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322033.RABTiuQaN6oCbIcyEUQggn1n0ZhIzG0Qr14xefF1llhes130_provenance.
- NP616696.RA7gImLh5Zn5RUFvyh9EY8bE7EqZVQ2n56y1qic5gn1nw130_assertion description "[The expression of CK5, EGFR, P-cadherin, CK14, Vimentin and p63 were evaluated in 462 invasive breast carcinomas to determine their sensitivity and specificity for BLBC identification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616696.RA7gImLh5Zn5RUFvyh9EY8bE7EqZVQ2n56y1qic5gn1nw130_provenance.
- NP883849.RA-HGVVjuV5RWReTk4pk_lKkvxhlzuYA-iKsqpIVR50d4130_assertion description "[The expression of CK5, EGFR, P-cadherin, CK14, Vimentin and p63 were evaluated in 462 invasive breast carcinomas to determine their sensitivity and specificity for BLBC identification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883849.RA-HGVVjuV5RWReTk4pk_lKkvxhlzuYA-iKsqpIVR50d4130_provenance.
- NP830310.RAykfiLIlpKyuhkDdrs8lWasp7aeH4pRsxh6NIaAvttdo130_assertion description "[The expression of CK5, EGFR, P-cadherin, CK14, Vimentin and p63 were evaluated in 462 invasive breast carcinomas to determine their sensitivity and specificity for BLBC identification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830310.RAykfiLIlpKyuhkDdrs8lWasp7aeH4pRsxh6NIaAvttdo130_provenance.
- NP767995.RASfQ2llf2jTvr8WrT9gGY5VgvMmrH6Vww8jK6UaUMc-o130_assertion description "[The expression of CK5, EGFR, P-cadherin, CK14, Vimentin and p63 were evaluated in 462 invasive breast carcinomas to determine their sensitivity and specificity for BLBC identification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767995.RASfQ2llf2jTvr8WrT9gGY5VgvMmrH6Vww8jK6UaUMc-o130_provenance.
- NP799796.RATIInVReLbJPE-k5Lb3fhr5isi8RKle9aZiXtor4Unfo130_assertion description "[The expression of CK5, EGFR, P-cadherin, CK14, Vimentin and p63 were evaluated in 462 invasive breast carcinomas to determine their sensitivity and specificity for BLBC identification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP799796.RATIInVReLbJPE-k5Lb3fhr5isi8RKle9aZiXtor4Unfo130_provenance.
- NP819216.RAmD-eQmaowkfSDEu11p72K8L9rcJhtz3CWNfAgzjO9ic130_assertion description "[The expression of CK5, EGFR, P-cadherin, CK14, Vimentin and p63 were evaluated in 462 invasive breast carcinomas to determine their sensitivity and specificity for BLBC identification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819216.RAmD-eQmaowkfSDEu11p72K8L9rcJhtz3CWNfAgzjO9ic130_provenance.
- NP819217.RAqj4fluEb18MdOW7PVqlExQONl57-99uadfAkR7oXbxg130_assertion description "[The expression of CK5, EGFR, P-cadherin, CK14, Vimentin and p63 were evaluated in 462 invasive breast carcinomas to determine their sensitivity and specificity for BLBC identification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819217.RAqj4fluEb18MdOW7PVqlExQONl57-99uadfAkR7oXbxg130_provenance.
- NP819222.RAlfOl2pkrskjKC50N0cxs4AWJi2a3JPGolA9hink6kOo130_assertion description "[The expression of CK5, EGFR, P-cadherin, CK14, Vimentin and p63 were evaluated in 462 invasive breast carcinomas to determine their sensitivity and specificity for BLBC identification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819222.RAlfOl2pkrskjKC50N0cxs4AWJi2a3JPGolA9hink6kOo130_provenance.
- NP819220.RAEZkWYM5L_DUMUmZYz0GUkMzWq7ZuK1m_zXetubhk0pQ130_assertion description "[The expression of CK5, EGFR, P-cadherin, CK14, Vimentin and p63 were evaluated in 462 invasive breast carcinomas to determine their sensitivity and specificity for BLBC identification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819220.RAEZkWYM5L_DUMUmZYz0GUkMzWq7ZuK1m_zXetubhk0pQ130_provenance.
- NP674932.RA05p-7Mo2YGjI4krpkxcXZBufVXN7YOTsAgJCGwR8nio130_assertion description "[The expression of CK5, EGFR, P-cadherin, CK14, Vimentin and p63 were evaluated in 462 invasive breast carcinomas to determine their sensitivity and specificity for BLBC identification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674932.RA05p-7Mo2YGjI4krpkxcXZBufVXN7YOTsAgJCGwR8nio130_provenance.
- NP857207.RA7TErLjapPj8oaEHgQbKBFMftEaNBNeMrI2DHwgrMbSs130_assertion description "[The expression of CK5, EGFR, P-cadherin, CK14, Vimentin and p63 were evaluated in 462 invasive breast carcinomas to determine their sensitivity and specificity for BLBC identification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857207.RA7TErLjapPj8oaEHgQbKBFMftEaNBNeMrI2DHwgrMbSs130_provenance.